Replies to post #242564 on Biotech Values

[DewDiligence]

[OT]—

Is it accepted dogma that T causes ovarian CA in trans males?

No, it isn’t. But the reason T therapy isn’t considered relevant may be more political than medical.

[DewDiligence]

Re: Alternative to CA125 for ovarian-cancer detection

https://www.businesswire.com/news/home/20220527005085/en

Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that the Mercy Halo Ovarian Cancer (OC) assay substantially outperformed CA125 when distinguishing patients with early-stage high-grade serious ovarian cancer (HGSOC) from women with benign conditions in a new study to be presented next week at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting. The assay uses a novel method of analyzing biomarkers based on individual extracellular vesicles (EVs).

The company is private.